245 related articles for article (PubMed ID: 29254242)
1. A comprehensive genomic meta-analysis identifies confirmatory role of
Rajendran BK; Deng CX
Oncotarget; 2017 Nov; 8(60):102263-102276. PubMed ID: 29254242
[TBL] [Abstract][Full Text] [Related]
2.
Guardia T; Zhang Y; Thompson KN; Lee SJ; Martin SS; Konstantopoulos K; Kontrogianni-Konstantopoulos A
Proc Natl Acad Sci U S A; 2023 Mar; 120(11):e2215553120. PubMed ID: 36877839
[TBL] [Abstract][Full Text] [Related]
3. Obscurin variants and inherited cardiomyopathies.
Marston S
Biophys Rev; 2017 Jun; 9(3):239-243. PubMed ID: 28510120
[TBL] [Abstract][Full Text] [Related]
4. Obscurin: A multitasking giant in the fight against cancer.
Guardia T; Eason M; Kontrogianni-Konstantopoulos A
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188567. PubMed ID: 34015411
[TBL] [Abstract][Full Text] [Related]
5. Novel OBSCN variants associated with a risk to exercise-intolerance and rhabdomyolysis.
Zemorshidi F; Töpf A; Claeys KG; McFarlane A; Patton A; Nafissi S; Straub V
Neuromuscul Disord; 2024 Jan; 34():83-88. PubMed ID: 38159459
[TBL] [Abstract][Full Text] [Related]
6. OBSCN Mutations Associated with Dilated Cardiomyopathy and Haploinsufficiency.
Marston S; Montgiraud C; Munster AB; Copeland O; Choi O; Dos Remedios C; Messer AE; Ehler E; Knöll R
PLoS One; 2015; 10(9):e0138568. PubMed ID: 26406308
[TBL] [Abstract][Full Text] [Related]
7. Intracellular calcium current disorder and disease phenotype in
Chen P; Xiao Y; Wang Y; Zheng Z; Chen L; Yang X; Li J; Wu W; Zhang S
Theranostics; 2020; 10(24):11215-11229. PubMed ID: 33042279
[TBL] [Abstract][Full Text] [Related]
8. Giant obscurin regulates migration and metastasis via RhoA-dependent cytoskeletal remodeling in pancreatic cancer.
Tuntithavornwat S; Shea DJ; Wong BS; Guardia T; Lee SJ; Yankaskas CL; Zheng L; Kontrogianni-Konstantopoulos A; Konstantopoulos K
Cancer Lett; 2022 Feb; 526():155-167. PubMed ID: 34826548
[TBL] [Abstract][Full Text] [Related]
9. Alterations in cytoskeletal and Ca
Grogan A; Huang W; Brong A; Kane MA; Kontrogianni-Konstantopoulos A
Front Cardiovasc Med; 2023; 10():1085840. PubMed ID: 37304957
[TBL] [Abstract][Full Text] [Related]
10. Loss of giant obscurins from breast epithelium promotes epithelial-to-mesenchymal transition, tumorigenicity and metastasis.
Shriver M; Stroka KM; Vitolo MI; Martin S; Huso DL; Konstantopoulos K; Kontrogianni-Konstantopoulos A
Oncogene; 2015 Aug; 34(32):4248-59. PubMed ID: 25381817
[TBL] [Abstract][Full Text] [Related]
11. Obscure functions: the location-function relationship of obscurins.
Manring HR; Carter OA; Ackermann MA
Biophys Rev; 2017 Jun; 9(3):245-258. PubMed ID: 28510116
[TBL] [Abstract][Full Text] [Related]
12. Impaired Intracellular Ca
Pierantozzi E; Szentesi P; Paolini C; Dienes B; Fodor J; Oláh T; Colombini B; Rassier DE; Rubino EM; Lange S; Rossi D; Csernoch L; Bagni MA; Reggiani C; Sorrentino V
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163243
[TBL] [Abstract][Full Text] [Related]
13. Bi-allelic loss-of-function OBSCN variants predispose individuals to severe recurrent rhabdomyolysis.
Cabrera-Serrano M; Caccavelli L; Savarese M; Vihola A; Jokela M; Johari M; Capiod T; Madrange M; Bugiardini E; Brady S; Quinlivan R; Merve A; Scalco R; Hilton-Jones D; Houlden H; Aydin HI; Ceylaner S; Drewes S; Vockley J; Taylor RL; Folland C; Kelly A; Goullee H; Ylikallio E; Auranen M; Tyynismaa H; Udd B; Forrest ARR; Davis MR; Bratkovic D; Manton N; Robertson T; O'Gorman C; McCombe P; Laing NG; Phillips L; de Lonlay P; Ravenscroft G
Brain; 2022 Nov; 145(11):3985-3998. PubMed ID: 34957489
[TBL] [Abstract][Full Text] [Related]
14. Proteomic Analysis of Myocardia Containing the Obscurin R4344Q Mutation Linked to Hypertrophic Cardiomyopathy.
Hu LR; Kontrogianni-Konstantopoulos A
Front Physiol; 2020; 11():478. PubMed ID: 32528308
[TBL] [Abstract][Full Text] [Related]
15. A novel missense mutation in obscurin gene in a Chinese consanguineous family with left ventricular noncompaction.
Dong XQ; Qin PP; Zhang D; Zhang QY; Qu Y; Zhao L; Lu YT; Hu YX; Yang CX; Liu XC; Liu YX; Zhou XL
J Geriatr Cardiol; 2022 Jul; 19(7):531-538. PubMed ID: 35975021
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of suppressor of cytokine signaling proteins in human breast Cancer.
Sun M; Tang C; Liu J; Jiang W; Yu H; Dong F; Huang C; Rixiati Y
BMC Cancer; 2021 Jun; 21(1):696. PubMed ID: 34120621
[TBL] [Abstract][Full Text] [Related]
17. Obscurins: unassuming giants enter the spotlight.
Perry NA; Ackermann MA; Shriver M; Hu LY; Kontrogianni-Konstantopoulos A
IUBMB Life; 2013 Jun; 65(6):479-86. PubMed ID: 23512348
[TBL] [Abstract][Full Text] [Related]
18. Obscurins: Goliaths and Davids take over non-muscle tissues.
Ackermann MA; Shriver M; Perry NA; Hu LY; Kontrogianni-Konstantopoulos A
PLoS One; 2014; 9(2):e88162. PubMed ID: 24516603
[TBL] [Abstract][Full Text] [Related]
19. Loss of giant obscurins promotes breast epithelial cell survival through apoptotic resistance.
Perry NA; Shriver M; Mameza MG; Grabias B; Balzer E; Kontrogianni-Konstantopoulos A
FASEB J; 2012 Jul; 26(7):2764-75. PubMed ID: 22441987
[TBL] [Abstract][Full Text] [Related]
20. Identifies microtubule-binding protein
Wang W; Zhang J; Wang Y; Xu Y; Zhang S
Comput Struct Biotechnol J; 2022; 20():3322-3335. PubMed ID: 35832625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
